[go: up one dir, main page]

ES429949A1 - A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES. - Google Patents

A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.

Info

Publication number
ES429949A1
ES429949A1 ES429949A ES429949A ES429949A1 ES 429949 A1 ES429949 A1 ES 429949A1 ES 429949 A ES429949 A ES 429949A ES 429949 A ES429949 A ES 429949A ES 429949 A1 ES429949 A1 ES 429949A1
Authority
ES
Spain
Prior art keywords
group
formula
alkyl
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES429949A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES429949A1 publication Critical patent/ES429949A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

A procedure for the preparation of benzylpyrimidine derivatives of the general formula **(See formula)** in which R1 and R2 each independently represent a C1-3alkyl, C1-3alkoxy, C2-3alkenyl or C2-3alkenyloxy group, Z represents a nitro, amino, pyrrolo, pyrrolidino piperidino group, -NHR4, -N (R4), -NHR5, -N (R4) (R5), -NR4COOR4, -NHCOOR4, -RHCONHR3, -NHCSNHR3, R4 represents a C1-3 alkyl or C2-3 alkenyl group, R5 represents an acyl group R3 represents a hydrogen atom or a group of C1-3 alkyl or C2-3 alkenyl and its salts, the process of which comprises reacting a compound of the general formula **(See formula)** where R6 represents a lower alkyl group or the two symbols R6 together represent a lower alkylene group, Y represents a leaving group and Z, R1, R2, R3, R4 and R5 have the aforementioned meaning, with guanidine and converting, if desired, a compound obtained from formula I into a salt. (Machine-translation by Google Translate, not legally binding)
ES429949A 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES. Expired ES429949A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1305773A CH591456A5 (en) 1973-09-12 1973-09-12

Publications (1)

Publication Number Publication Date
ES429949A1 true ES429949A1 (en) 1976-10-01

Family

ID=4388903

Family Applications (7)

Application Number Title Priority Date Filing Date
ES429949A Expired ES429949A1 (en) 1973-09-12 1974-09-11 A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.

Family Applications After (6)

Application Number Title Priority Date Filing Date
ES437012A Expired ES437012A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437011A Expired ES437011A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437009A Expired ES437009A1 (en) 1973-09-12 1975-04-25 Benzylpyrimidine derivatives
ES437008A Expired ES437008A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.
ES437007A Expired ES437007A1 (en) 1973-09-12 1975-04-25 PROCEDURE FOR THE PREPARATION OF BENZYLPIRIMIDINE DERIVATIVES.
ES437013A Expired ES437013A1 (en) 1973-09-12 1975-04-25 A PROCEDURE FOR THE PREPARATION OF BENZYL-PYRIMIDINE DERIVATIVES.

Country Status (28)

Country Link
JP (1) JPS6042238B2 (en)
AR (2) AR207764A1 (en)
AT (1) AT338797B (en)
BE (1) BE819773A (en)
BR (1) BR7407614D0 (en)
CA (1) CA1037476A (en)
CH (1) CH591456A5 (en)
CU (1) CU34115A (en)
DD (2) DD116824A5 (en)
DE (1) DE2443682C2 (en)
DK (1) DK135683B (en)
ES (7) ES429949A1 (en)
FI (1) FI58638C (en)
FR (1) FR2242984B1 (en)
GB (3) GB1484483A (en)
HK (1) HK181A (en)
HU (1) HU170427B (en)
IE (1) IE40523B1 (en)
IL (1) IL45510A (en)
LU (1) LU70878A1 (en)
NL (1) NL155827B (en)
NO (1) NO140858C (en)
PH (1) PH10643A (en)
PL (2) PL99159B1 (en)
SE (1) SE419443B (en)
SU (3) SU577987A3 (en)
YU (3) YU217874A (en)
ZA (1) ZA745317B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515948A (en) * 1973-09-12 1985-05-07 Hoffmann-La Roche Inc. 2,4-Diamino-5-(4-amino and 4-dimethylamino-3,5-dimethoxy benzyl)pyrimidines
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH639273A5 (en) * 1978-09-12 1983-11-15 Hoffmann La Roche DIURETIC MEANS.
JPS5888368A (en) * 1981-11-09 1983-05-26 ザ・ウエルカム・フアウンデ−シヨン・リミテツド Manufacture of benzylpyrimidine derivative
DE3250132C2 (en) * 1981-11-09 1997-01-16 Mallinckrodt Veterinary Inc 2,4-Di:amino-5-benzyl-pyrimidine derivs. prepn.
GB2180836A (en) * 1985-09-27 1987-04-08 William James Stephen Barker Sunscreen
CA1300166C (en) * 1987-12-03 1992-05-05 Alfredo Guerrato Process for the preparation of a benzoic acid ester
US4900859A (en) * 1987-12-03 1990-02-13 Hoffman-La Roche Inc. Process for 4-dimethylamino-3,5-dimethoxybenzaldehyde

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1103931B (en) * 1957-02-21 1961-04-06 Wellcome Found Process for the preparation of 2,4-diamino-5-benzylpyrimidine derivatives
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes

Also Published As

Publication number Publication date
DD116824A5 (en) 1975-12-12
ES437012A1 (en) 1977-04-01
YU301680A (en) 1983-04-27
YU37153B (en) 1984-08-31
SU571189A3 (en) 1977-08-30
FI58638B (en) 1980-11-28
FI58638C (en) 1981-03-10
CU21022L (en) 1981-09-09
FR2242984A1 (en) 1975-04-04
SU577987A3 (en) 1977-10-25
GB1484481A (en) 1977-09-01
DK135683C (en) 1977-11-14
BR7407614D0 (en) 1975-07-08
FI256174A7 (en) 1975-03-13
PH10643A (en) 1977-07-22
YU217874A (en) 1982-06-18
PL99159B1 (en) 1978-06-30
CH591456A5 (en) 1977-09-15
NO140858C (en) 1979-11-28
AR211387Q (en) 1977-12-15
SE7411382L (en) 1975-03-13
ZA745317B (en) 1975-11-26
NO140858B (en) 1979-08-20
NL155827B (en) 1978-02-15
AR207764A1 (en) 1976-10-29
CU34115A (en) 1983-10-04
PL97757B1 (en) 1978-03-30
IL45510A (en) 1978-08-31
GB1484483A (en) 1977-09-01
SU609465A3 (en) 1978-05-30
ES437009A1 (en) 1977-04-01
ES437008A1 (en) 1977-04-01
IE40523L (en) 1975-03-12
JPS5053385A (en) 1975-05-12
DD122785A5 (en) 1976-11-05
DK468374A (en) 1975-05-12
IE40523B1 (en) 1979-06-20
SE419443B (en) 1981-08-03
CA1037476A (en) 1978-08-29
NL7411685A (en) 1975-03-14
DE2443682A1 (en) 1975-03-20
BE819773A (en) 1975-03-11
YU37154B (en) 1984-08-31
LU70878A1 (en) 1976-08-19
ES437007A1 (en) 1977-04-01
HU170427B (en) 1977-06-28
FR2242984B1 (en) 1977-11-04
HK181A (en) 1981-01-16
AU7263174A (en) 1976-02-26
AT338797B (en) 1977-09-12
ATA735174A (en) 1977-01-15
ES437011A1 (en) 1977-04-01
JPS6042238B2 (en) 1985-09-20
DE2443682C2 (en) 1983-11-10
IL45510A0 (en) 1974-11-29
GB1484482A (en) 1977-09-01
YU301580A (en) 1983-04-27
NO743271L (en) 1975-04-07
DK135683B (en) 1977-06-06
ES437013A1 (en) 1977-04-01

Similar Documents

Publication Publication Date Title
ES441673A1 (en) A PROCEDURE FOR THE PREPARATION OF BIGUANIDA SALTS.
ES457105A1 (en) PROCEDURE FOR THE PREPARATION OF NEW ACETOHYDROXAMIC ACIDS.
ES309169A1 (en) A PROCEDURE FOR THE PREPARATION OF BENZODIAZEPINE DERIVATIVES.
SE7704783L (en) Means FOR SEPARATION AND PROCEDURES FOR ITS PRODUCTION
ES429949A1 (en) A PROCEDURE FOR THE PREPARATION OF BENZYLPYRIMIDINE DERIVATIVES.
ES345003A1 (en) Process for making dihydroquinazolines
GB1433920A (en) Alkanolamine derivatives
ES417638A1 (en) PROCEDURE TO PREPARE 2,4,5-TRISUSTITUED OXAZOLES.
SE7408124L (en) METHODS OF PRODUCING SULFAMOYLBENZOIC ACID AMIDES.
ES530762A0 (en) PROCEDURE FOR PREPARING NEW BIS- (PIPERAZINIL-U HOMOPIPERAZINIL) -ALCANOS
ES427185A1 (en) Butyramides and butyrates
ES394761A1 (en) 2-amino-1,5-benzodiazocine derivatives
ES419386A1 (en) Indenopyrrole derivatives
ES423745A1 (en) Procedure for preparing 2-aminoindane derivatives. (Machine-translation by Google Translate, not legally binding)
ES387921A1 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF DIFNILTETRAFLUORETHANE.
ES472572A1 (en) F3-phenoxy-n-substituted morphinan derivatives their manufacture and pharmaceutical preparations containing them
ES411327A1 (en) A PROCEDURE FOR THE PREPARATION OF NEW BENZYLPIRIMIDINS.
ES441429A2 (en) PROCEDURE FOR THE PRODUCTION OF AZOIC COMPOUNDS.
ES428457A1 (en) Preparation of salicylamide derivatives
ES373884A1 (en) Procedure for the preparation of phenyl butazone derivatives. (Machine-translation by Google Translate, not legally binding)
ES375525A1 (en) A procedure for the preparation of N-substitute and n, N-disstituted aminocarbonylalkilic compounds. (Machine-translation by Google Translate, not legally binding)
ES428624A1 (en) Procedure for the preparation of pyrimidine derivatives. (Machine-translation by Google Translate, not legally binding)
ES398968A1 (en) PROCEDURE FOR OBTAINING DERIVATIVES OF 1,2,4 PIRIMIDO (4,5-E) TIADICIN.
ES442128A1 (en) Fluoran compounds and their use in pressure-sensitive copying paper
ES419853A1 (en) Procedure for the obtaining of substitute arilic amines. (Machine-translation by Google Translate, not legally binding)